Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

BACKGROUND:Despite its recommendation by the current guidelines, the role of long-term oral beta-blocker therapy has never been evaluated by randomized trials in uncomplicated ST-segment elevation myocardial infarction (STEMI) patients without heart failure, left ventricular dysfunction or ventricul...

Full description

Bibliographic Details
Main Authors: Hiroki Watanabe, Neiko Ozasa, Takeshi Morimoto, Hiroki Shiomi, Bao Bingyuan, Satoru Suwa, Yoshihisa Nakagawa, Chisato Izumi, Kazushige Kadota, Shigeru Ikeguchi, Kiyoshi Hibi, Yutaka Furukawa, Shuichiro Kaji, Takahiko Suzuki, Masaharu Akao, Tsukasa Inada, Yasuhiko Hayashi, Mamoru Nanasato, Masaaki Okutsu, Ryosuke Kametani, Takahito Sone, Yoichi Sugimura, Kazuya Kawai, Mitsunori Abe, Hironori Kaneko, Sunao Nakamura, Takeshi Kimura, CAPITAL-RCT investigators
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6112626?pdf=render

Internet

http://europepmc.org/articles/PMC6112626?pdf=render

Similar Items